{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:30:20Z","timestamp":1788867020122,"version":"build-2803163510"},"reference-count":16,"publisher":"Baishideng Publishing Group Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2005]]},"DOI":"10.3748\/wjg.v11.i9.1382","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T05:43:40Z","timestamp":1416548620000},"page":"1382","source":"Crossref","is-referenced-by-count":23,"title":["Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma"],"prefix":"10.3748","volume":"11","author":[{"given":"Bu-Dong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Nakakura EK, Choti MA. Management of hepatocellular carcinoma. Oncology (Williston Park) 2000;14:1085-1098; discussion 1098-1102.","DOI":"10.1007\/s004640080142"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/1040-8428(94)00144-I"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Wu BW, Wu Y, Wang JL, Lin JS, Yuan SY, Li A, Cui WR. Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cells. World J Gastroenterol 2003;9:271-275.","DOI":"10.3748\/wjg.v9.i2.271"},{"key":"ref4","unstructured":"Zhu BD, Yuan SJ, Xu JM, Zhao QC, Li X, Li Y, Hao LH. The effect of IRESSA on H22 mouse hepatocellular carcinoma. Zhonghua YiXue ZaZhi 2004;84:684-686."},{"key":"ref5","unstructured":"Ciardiello F, Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 2001;7:2958-2970."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.11.6.837"},{"key":"ref7","unstructured":"Matsuo M, Sakurai H, Saiki I. ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma model. Mol Cancer Ther 2003;2:557-561."},{"key":"ref8","unstructured":"Wakeling AE, Guy SP, Woodburn JR, Ashton SE, Curry BJ, Barker AJ, Gibson KH. ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res 2002;62:5749-5754."},{"key":"ref9","unstructured":"Ciardiello F, Caputo R, Bianco R, Damiano V, Fontanini G, Cuccato S, De Placido S, Bianco AR, Tortora G. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res 2001;7:1459-1465."},{"key":"ref10","unstructured":"Hirata A, Ogawa S, Kometani T, Kuwano T, Naito S, Kuwano M, Ono M. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res 2002;62:2554-2560."},{"key":"ref11","unstructured":"Sirotnak FM, Zakowski MF, Miller VA, Scher HI, Kris MG. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin Cancer Res 2000;6:4885-4892."},{"key":"ref12","unstructured":"Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S, Bianco AR, Tortora G. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer Res 2000;6:2053-2063."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.16.2149"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.038"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.07.215"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.001"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v11\/i9\/1382.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T17:05:37Z","timestamp":1566061537000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v11\/i9\/1382.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v11.i9.1382","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]}}}